— Know what they know.
Not Investment Advice

COLL NASDAQ

Collegium Pharmaceutical, Inc.
1W: -1.2% 1M: +4.1% 3M: -23.5% YTD: -24.4% 1Y: +14.9% 3Y: +49.5% 5Y: +50.9%
$34.07
-0.35 (-1.02%)
After Hours: $33.27 (-0.80, -2.36%)
Weekly Expected Move ±6.5%
$29 $32 $34 $36 $38
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 50 · $1.1B mcap · 32M float · 1.71% daily turnover · Short 57% of daily vol

Cash Flow Trends

Operating Cash Flow
$329M +60.7% ▲
5Y CAGR: +28.5%
Capital Expenditures
$2M -5.3% ▼
5Y CAGR: -65.8%
Free Cash Flow
$328M +61.1% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$25M +58.2% ▲
Net Change in Cash
$156M +208.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$72M-$25M$48M$69M$63M
Depreciation & Amort.$69M$139M$149M$169M$221M
Stock-Based Comp.$24M$23M$27M$32M$42M
Change in Working Capital$13M-$13M$22M-$55M$4M
Other Non-Cash Items$3M$9M$31M$16M$26M
Operating Cash Flow$104M$124M$275M$205M$329M
— Investing Activities —
Capital Expenditures-$2M-$2M-$461K-$2M-$2M
Acquisitions (Net)$0-$572M$0-$268M$0
Investment Purchases$0$0-$92M-$111M-$127M
Investment Sales$0$0$22M$93M$65M
Other Investing$0$0$0$0$0
Investing Cash Flow-$2M-$574M-$71M-$288M-$64M
— Financing Activities —
Net Debt Issuance-$50M$443M-$66M$8M-$70M
Stock Repurchased-$48M-$14M-$75M-$60M-$25M
Dividends Paid$0$0$0$0$0
Other Financing$9M$8M$740K-$8M-$20M
Financing Cash Flow-$89M$437M-$140M-$61M-$110M
Net Change in Cash$12M-$13M$64M-$143M$156M
Cash End of Period$189M$176M$240M$97M$252M
Free Cash Flow$102M$123M$274M$203M$328M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms